Joinn laboratories (06127.HK) announced the performance for the first three quarters ending in September, achieving revenue of 1.335 billion RMB under China Accounting Standards, a year-on-year decrease of 15.9%. Recording a loss of 70.31 million yuan, compared to a net profit of 0.328 billion yuan in the same period last year, a shift from profit to loss, attributed to intensified competition, decrease in sales revenue and gross margin, as well as a decrease in the fair value of biological assets; loss per share of 9 cents.